A 17-year-old Aboriginal boy from a remote Northern Territory community has a history of definite acute rheumatic fever with carditis at age 12 and established rheumatic mitral regurgitation. He weighs 65 kg, has no penicillin allergy and remains in his community. According to the 2020 Australian rheumatic heart disease guideline, what is the preferred secondary prophylaxis regimen?